help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on November 19, 2004, doi:10.1164/rccm.200404-446OC

Am. J. Respir. Crit. Care Med., Volume 171, Number 4, February 2005, 354-360

A more recent version of this article appeared on February 15, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200404-446OCv1
171/4/354    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayr, F. B
Right arrow Articles by Jilma, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayr, F. B
Right arrow Articles by Jilma, B.

Submitted on April 2, 2004
Accepted on November 15, 2004

Effects of Carbon Monoxide Inhalation during Experimental Endotoxemia in Humans

Florian B Mayr1, Alexander Spiel1, Judith Leitner1, Claudia Marsik2, Peter Germann3, Roman Ullrich3, Oswald Wagner2, and Bernd Jilma1*

1 Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria, 2 Department of Medical and Chemical Laboratory Diagnostics, Medical University Vienna, Vienna, Austria, 3 Department of Anesthesiology and General Critical Care Medicine, Medical University Vienna, Vienna, Austria

* To whom correspondence should be addressed. E-mail: Bernd.Jilma{at}meduniwien.ac.at.

Recent data show that carbon monoxide (CO) exerts direct anti-inflammatory effects in vitro and in vivo after lipopolysaccharide (LPS) challenge in a mouse model. We hypothesized that CO may act as an anti-inflammatory agent in human endotoxemia. The aim of this trial was to study the effects of CO inhalation on cytokine production during experimental human endotoxemia. The main study was randomized, double-blinded, placebo-controlled two-way crossover in healthy volunteers. Each volunteer inhaled synthetic air (as placebo) and 500 ppm CO for 1 hour in random order with a washout period of 6 weeks and received a 2 ng/kg intravenous bolus of LPS after inhalation. HbCO levels were assessed as a safety parameter. CO inhalation increased HbCO levels from 1.2% [95%CI: 1.0-1.4%] to peak values of 7.0 [CI:6.5-7.7%]. LPS infusion transiently increased plasma concentrations of TNF{alpha}, IL-6 (~150-fold increases), IL-8 as well as IL-1{alpha}+{beta} mRNA levels (~200-fold increase). These LPS-induced changes were not influenced by CO inhalation. Inhalation of 500 ppm CO for 1 hour had no anti-inflammatory effects in a systemic inflammation model in humans as 250 ppm for 1 hour did in rodents.


Key words: CO, endotoxin, TNF, HbCO




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Wang, J.-Y. S. Lee, J. H. Kwak, Y. He, S. I. Kim, and M. E. Choi
Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction
Am J Physiol Renal Physiol, March 1, 2008; 294(3): F508 - F517.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Sauermann, C. Marsik, I. Steiner, K. Seir, T. Cvitko, M. Zeitlinger, O. Wagner, and C. Joukhadar
Immunomodulatory Effects of Fosfomycin in Experimental Human Endotoxemia
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1879 - 1881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. W. Ryter, D. Morse, and A. M. K. Choi
Carbon Monoxide and Bilirubin: Potential Therapies for Pulmonary/Vascular Injury and Disease
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 833 - 841.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. B. Hampson, L. K. Weaver, and C. A. Piantadosi
"Low-Level" Carbon Monoxide Administration May Carry Risk
Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 784 - 784.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Mayr, M. Bilban, and B. Jilma
"Low-Level" Carbon Monoxide Administration May Carry Risk
Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 784 - 785.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society
  2009 ATS Conference Fees